High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort

RAS and BRAF mutations impact treatment and prognosis of metastatic colorectal cancer patients (mCRC), but the knowledge is based on trial patients usually not representative for the general cancer population. Patient characteristics, treatment and efficacy according to KRAS, BRAF and MSI status wer...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:PLoS One
Main Authors: Sorbye, Halfdan, Dragomir, Anca, Sundström, Magnus, Pfeiffer, Per, Thunberg, Ulf, Bergfors, Monica, Aasebø, Kristine, Eide, Geir Egil, Ponten, Fredrik, Qvortrup, Camilla, Glimelius, Bengt
פורמט: Artigo
שפה:Inglês
יצא לאור: Public Library of Science 2015
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4484806/
https://ncbi.nlm.nih.gov/pubmed/26121270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0131046
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים